ResearcherJohns Hopkins UniversityNo recent work listed

Mohit Philip Mathew

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7049-6660; OpenAlex author ID A5061147682. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper

Papers 2

Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic c… Co-author DOI 10.18632/oncotarget.11582 ↗
Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib. Co-author DOI 10.1016/j.bmcl.2015.01.060 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kevin J Yarema · 2 shared papers, 2015–2016 · strength 0.12
- Paper Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth facto… DOI 10.18632/oncotarget.11582 ↗
- Paper Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib an… DOI 10.1016/j.bmcl.2015.01.060 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.